ArticleCancers2023

Survival Benefit of Renin-Angiotensin System Blockers in Critically Ill Cancer Patients: A Retrospective Study.

Driss Laghlam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.